RSV-M-203: Study M-203 - A Phase II Randomized, Observer-blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) Fusion (F)

Administered By

Awarded By

Contributors

Start/End

  • October 1, 2014 - May 15, 2017